Pfizer's Anti-Cancer Drug Survives EU Patent Challenge
Pfizer has won its bid to patent a drug used to treat ovarian cancer, after its rival Hexal AG failed to convince the European Patent Office that the invention was not...To view the full article, register now.
Already a subscriber? Click here to view full article